Indiana AG Todd Rokita touts 'monumental victory' in Sackler family, Purdue opioid settlement
Indiana will receive up to $100 million to support addiction recovery programs as part of the largest settlement to date holding suppliers accountable for their role in the opioid crisis, according to Indiana Attorney General Todd Rokita.
In all, $7.4 billion will be dispersed to dozens of states and territories across the U.S. The Sackler family and Purdue Pharma were ordered to pay for "aggressive marketing of opioid products" that "fueled the worst drug crisis in U.S. history," Rokita said.
Rokita called the settlement a "monumental victory" for Hoosiers. In Marion County, fentanyl kills more people than homicides and car crashes combined.
Drug addiction in Indiana: What a grieving mother's story shows us about the fentanyl crisis in Indianapolis
In 2020, Purdue Pharma admitted to paying doctors to encourage them to prescribe more opioids and impeding the U.S. Drug Enforcement Administration's effort to fight the burgeoning epidemic. The settlement also permanently ends the Sackler family's control of Purdue Pharma, according to the Attorney General's office, and prohibits them from participating in the U.S. opioid industry.
Indiana's funds will be released over the next 15 years. Most will be dispersed in the first three years.
"This is about accountability and justice," said Rokita.
A Marion County program that alerts recipients about bad drug batches or overdose spikes can be accessed by texting SOAR to 765-358-7627.
If you or a loved one is struggling with mental health or substance abuse problems, contact the Substance Abuse and Mental Health Services Administration at 1-800-662-HELP (4357) for help.
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Indianapolis Star
a day ago
- Indianapolis Star
Hoosiers could be kicked off Medicaid under Trump's 'big beautiful bill.' What to know
Some Hoosiers could be kicked off Medicaid if President Donald Trump's 'One Big Beautiful Bill Act' passes in its current form, as the state grapples with the revenue cuts that would come with it. Language added to the federal legislation on June 16 caps the Medicaid provider tax — which is used to cover 90% of the state's portion of the costs for the Healthy Indiana Plan — at 3.5%. Indiana utilizes a 6% provider tax, meaning the change would decrease funding from the fee by nearly half. Opponents of the provider tax view it as a loophole used by states to qualify for matching dollars from the federal government, which pays for 90% of the costs of the program, without having to dedicate much of their own funds. If passed as is, Indiana would not be able to afford the current costs of the Healthy Indiana Plan, the state's insurance program for low-income people, Indiana Family and Social Services Administration Secretary Mitch Roob said at a state budget committee meeting June 18. But neither Roob nor Gov. Mike Braun are asking Congress to keep the full 6%. Instead, Roob said at the meeting that he wants Congress to add language that would give states the flexibility to adapt. Those changes would allow the state to enroll fewer Hoosiers in HIP, according to Roob. 'Please give us the needed flexibility to roll back our eligibility if they change the fuel mix for our program,' he said at the meeting. Even without the added impact of the federal legislation, the state is making it more challenging to qualify for Medicaid. The latest version of HIP already includes more restrictions, such as work requirements for able-bodied recipients that passed the legislature this year. The new law includes a list of exceptions, though not all would be covered under the work requirement language proposed in the federal bill. In a statement June 18, Braun said the efforts to reduce federal spending were overdue. "However, flexibility in managing Indiana's HIP program will be essential for the state moving forward, especially if we are required to take on more of the financial obligation,' he said in the statement. 'This will require a hands-on approach to updating and maintaining Indiana's Medicaid system that only Hoosiers can provide.' Braun said he would work to 'stretch the dollar' for people with chronic diseases and those who 'really can't afford health care' when speaking to reporters at the Indiana Statehouse on June 19. 'That's what I'd like to have it there for, not what it's expanded into with very lax supervision, pushed by the feds and now with a bunch of begrudging state partners because it's been busting the budget,' he said. The provision has already faced some GOP opposition in the U.S. House of Representatives, which must approve this version of the bill before it can move on. With a slim Republican majority, it's possible the part of the bill that imposes the 3.5% tax cap could be removed. The version that already passed the House only capped future increases in provider fees.
Washington Post
4 days ago
- Washington Post
A judge could advance Purdue Pharma's $7B opioid settlement after all 50 states back it
All 50 U.S. states have agreed to the OxyContin maker Purdue Pharma 's latest plan to settle thousands of lawsuits over the toll of opioids . A judge on Wednesday is being asked to clear the way for local governments and individual victims to vote on it. Government entities, emergency room doctors, insurers, families of children born into withdrawal from the powerful prescription painkiller, individual victims and their families and others would have until Sept. 30 to vote on whether to accept the deal, which calls for members of the Sackler family who own the company to pay up to $7 billion over 15 years.
Yahoo
4 days ago
- Yahoo
Utah to sign $57 million settlement with Purdue Pharma over its role in opioid crisis
Utah Attorney General Derek Brown talks to reporters during his first press conference at the Utah State Capitol Building on Thursday, Jan. 9, 2025. (Kyle Dunphey/Utah News Dispatch) It's almost official. Utah is close to signing a settlement to receive $57 million in an agreement with the Sackler family and its former pharmaceutical company Purdue Pharma, the manufacturers of OxyContin, over their role in the country's opioid epidemic. In total, all 50 states, the District of Columbia and U.S. territories are soon to settle for $7.4 billion, according to the Utah Attorney General's Office, which described the agreement as 'monumental' and 'a critical step towards accountability.' In Utah the money will be used for efforts to combat the effects of the crisis in communities across the state. That's in addition to the $540 million the state is slated to receive from other settlements, with $275 million designated for the state and $265 million for counties. SUBSCRIBE: GET THE MORNING HEADLINES DELIVERED TO YOUR INBOX 'Utah families deserve this resolution after Purdue Pharma and the Sackler family recklessly harmed our communities, and contributed to the opioid epidemic,' Utah Attorney General Derek Brown said in a statement. 'I will continue to use all the tools I have available, including litigation and prosecution, to protect Utahns in the future from these deadly drugs.' Under the Sacklers' management, Purdue Pharma manufactured opioids like OxyContin, marketing it as a safe despite their knowledge of its highly addictive nature, the AG's office wrote in a release. The campaign led to a surge in opioid prescriptions in the state. Utah expected to join at least a dozen states in Purdue Pharma settlement The Utah Division of Consumer Protection has pursued an administrative action against the company, Richard Sackler and Kathe Sackler since 2019 with allegations that they participated in 'deceptive' practices, provided nearly $200,000 in gifts and payments to prescribers in Utah between 2013 and 2017, and employed 186 sales representatives in the state who conducted in-person marketing visits to 5,000 prescribers — all practices that intensified the opioid crisis here, the release says. The settlement establishes that the Sackler family will pay $6.5 billion in the next 15 years 'coming from Purdue Pharma upon its emergence from bankruptcy protection.' Additionally, the family won't be able to control the pharmaceutical company, the agreement says. It also restricts Purdue Pharma's opioid sales in the country. Between 2002 and 2015, opioid prescriptions surged by over one million, according to the AG's office. Between 2014 and 2019, prescription opioids caused 1,611 deaths in the state. The state has also reached settlements with major corporations including Walmart, Walgreens, Kroger, CVS, Publicis Health, McKinsey, Cardinal, Johnson & Johnson, Allergan, Teva, McKesson, AmerisourceBergen and Mallinckrodt. 'Purdue Pharma and the Sackler family caused immense harm and innumerable lives lost through their deceptive marketing and greed,' Margaret Woolley Busse, executive director of the Utah Department of Commerce said in a statement. 'Utah never stopped its work to hold Purdue and the Sacklers accountable for what they have done and the devastation they have caused.' SUPPORT: YOU MAKE OUR WORK POSSIBLE
